Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Automated Microbial Diagnostics01:24

Automated Microbial Diagnostics

Automated diagnostic analyzers have transformed clinical microbiology by providing rapid and reliable methods for pathogen identification and antibiotic susceptibility testing. Among these systems, the Vitek 2 is widely used because it automates the traditionally labor-intensive processes of microbial identification (ID) and antibiotic susceptibility testing (AST), delivering standardized and timely results that are essential for effective patient care.Microbial Identification with ID CardsThe...
Microbial Biosensors01:17

Microbial Biosensors

Microbial biosensors are analytical devices that utilize living microbes to detect specific substances through measurable signals. These devices consist of two main components: biosensing organisms and signal-transducing elements. Biosensing organisms, such as Escherichia coli or Saccharomyces cerevisiae, are typically housed in multiwell plates connected to transducers, enabling rapid, real-time detection of target analytes.Signal Generation MechanismWhen a target analyte—such as...
Rapid Identification of Pathogens01:25

Rapid Identification of Pathogens

MALDI-TOF MS has transformed clinical microbiology by offering a rapid and reliable method for pathogen identification. The traditional approach to microbial identification typically involves time-consuming culture techniques and biochemical tests, which can delay the initiation of appropriate antimicrobial therapy. MALDI-TOF MS avoids these delays by using characteristic ribosomal protein mass patterns of microbial cells, enabling accurate species-level identification within minutes.Principle...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

AFM visualization of immobilized horseradish peroxidase during its catalytic cycle.

Biomeditsinskaia khimiia·2026
Same author

Hyaluronic acid: biochemical properties and medical applications.

Biomeditsinskaia khimiia·2026
Same author

Vitaphospholip® (water-soluble phosphatidylcholine) in the treatment of combined hyperlipidemia: a randomized, placebo-controlled clinical trial.

Biomeditsinskaia khimiia·2025
Same author

The SPR analysis of the interaction of inactivated poliovirus vaccine attenuated strains with antibodies.

Biomeditsinskaia khimiia·2025
Same author

Advantages of aptamers as ligands upon protein detection by AFM-based fishing.

Analytical methods : advancing methods and applications·2025
Same author

AFM-fishing technology for protein detection in solutions.

Biomeditsinskaia khimiia·2024

Related Experiment Video

Updated: Jul 15, 2026

Registered Bioimaging of Nanomaterials for Diagnostic and Therapeutic Monitoring
17:16

Registered Bioimaging of Nanomaterials for Diagnostic and Therapeutic Monitoring

Published on: December 9, 2010

Analytical nanobiotechnology for medicine diagnostics.

A I Archakov1, Yu D Ivanov

  • 1Institute of Biomedical Chemistry RAMS, Moscow, Russia. archak@ibmc.msk.ru

Molecular Biosystems
|April 27, 2007
PubMed
Summary

Nanotechnology revolutionizes clinical proteomics by enabling sensitive detection of disease markers and rapid diagnostic systems. This review explores nanodevices for advanced proteomic analysis and genome sequencing.

Area of Science:

  • Biomedical Engineering
  • Nanotechnology
  • Clinical Proteomics

Background:

  • Clinical proteomics aims to identify protein biomarkers for disease diagnosis and monitoring.
  • Traditional proteomic methods face limitations in sensitivity and speed for clinical applications.
  • Nanotechnology offers novel tools and approaches to overcome these challenges.

Purpose of the Study:

  • To review the current state-of-the-art of nanotechnologies in clinical proteomics.
  • To discuss the future prospects and development of nanodevices for proteomic analysis.
  • To highlight the potential of nanotechnology in advancing diagnostic capabilities.

Main Methods:

  • Review of existing literature on nanotechnology applications in clinical proteomics.

More Related Videos

CRISPR-Cas-mediated Multianalyte Synthetic Urine Biomarker Test for Portable Diagnostics
04:33

CRISPR-Cas-mediated Multianalyte Synthetic Urine Biomarker Test for Portable Diagnostics

Published on: December 8, 2023

Nanosensors to Detect Protease Activity In Vivo for Noninvasive Diagnostics
10:50

Nanosensors to Detect Protease Activity In Vivo for Noninvasive Diagnostics

Published on: July 16, 2018

Related Experiment Videos

Last Updated: Jul 15, 2026

Registered Bioimaging of Nanomaterials for Diagnostic and Therapeutic Monitoring
17:16

Registered Bioimaging of Nanomaterials for Diagnostic and Therapeutic Monitoring

Published on: December 9, 2010

CRISPR-Cas-mediated Multianalyte Synthetic Urine Biomarker Test for Portable Diagnostics
04:33

CRISPR-Cas-mediated Multianalyte Synthetic Urine Biomarker Test for Portable Diagnostics

Published on: December 8, 2023

Nanosensors to Detect Protease Activity In Vivo for Noninvasive Diagnostics
10:50

Nanosensors to Detect Protease Activity In Vivo for Noninvasive Diagnostics

Published on: July 16, 2018

  • Discussion of advancements in atomic force microscopy for biomarker detection.
  • Exploration of nanosensor-based diagnostic systems and nanopore sequencing technologies.

    • Main Results:

    • Nanotechnology enables the detection of protein disease markers with ultra-high sensitivity (10^-17 M) using atomic force microscopy.
    • Nanosensoric elements (optical, electro-optical, electromechanical, electrochemical) facilitate high-speed diagnostic systems.
    • Nanopore-based devices show promise for rapid genome sequencing.

    Conclusions:

    • Nanotechnology is a transformative field for clinical proteomics, offering unprecedented sensitivity and speed.
    • The integration of nanodevices into clinical practice promises to significantly enhance disease diagnostics.
    • Future developments in nanotechnology will likely lead to more sophisticated and efficient proteomic and genomic analyses.